BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28061480)

  • 1. Co-ordinated overexpression of SIRT1 and STAT3 is associated with poor survival outcome in gastric cancer patients.
    Zhang S; Huang S; Deng C; Cao Y; Yang J; Chen G; Zhang B; Duan C; Shi J; Kong B; Friess H; Zhao N; Huang C; Huang X; Wang L; Zou X
    Oncotarget; 2017 Mar; 8(12):18848-18860. PubMed ID: 28061480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
    Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
    Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.
    Woo S; Lee BL; Yoon J; Cho SJ; Baik TK; Chang MS; Lee HE; Park JW; Kim YH; Kim WH
    Pathobiology; 2011; 78(6):295-301. PubMed ID: 22104200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1.
    Zhang LH; Huang Q; Fan XS; Wu HY; Yang J; Feng AN
    Pathol Res Pract; 2013 Oct; 209(10):611-7. PubMed ID: 24035280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
    Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
    APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 inhibits gastric cancer proliferation and metastasis via STAT3/MMP-13 signaling.
    Zhang S; Yang Y; Huang S; Deng C; Zhou S; Yang J; Cao Y; Xu L; Yuan Y; Yang J; Chen G; Zhou L; Lv Y; Wang L; Zou X
    J Cell Physiol; 2019 Sep; 234(9):15395-15406. PubMed ID: 30710340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
    Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
    Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D; Sabo E; Tavares R; Resnick MB
    Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
    Zhang XG; Song BT; Liu FJ; Sun D; Wang KX; Qu H
    Clin Transl Oncol; 2016 Jul; 18(7):700-7. PubMed ID: 26489425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer.
    Noguchi A; Kikuchi K; Zheng H; Takahashi H; Miyagi Y; Aoki I; Takano Y
    Cancer Med; 2014 Dec; 3(6):1553-61. PubMed ID: 25146318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
    Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
    Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer.
    Lee WS; Park YL; Kim N; Oh HH; Son DJ; Kim MY; Oak CY; Chung CY; Park HC; Kim JS; Myung DS; Cho SB; Joo YE
    Int J Oncol; 2015 May; 46(5):2154-62. PubMed ID: 25672320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
    Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
    Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis.
    Li X; Zhang Y; Cao S; Chen X; Lu Y; Jin H; Sun S; Chen B; Liu J; Ding J; Wu K; Fan D
    Int J Cancer; 2009 Feb; 124(3):713-21. PubMed ID: 18972434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.
    Yang Y; Cai J; Yin J; Wang D; Bai Z; Zhang J; Wang K; Yu G; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(10):12482-90. PubMed ID: 26722435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.